Results 21 to 30 of about 222,467 (377)

Use of fast-acting insulin aspart in insulin pump therapy in clinical practice. [PDF]

Diabetes Obes Metab, 2019
Fast‐acting insulin aspart (faster aspart) is a novel formulation of insulin aspart (IAsp) containing the additional excipients niacinamide and L‐arginine.
Evans M, Ceriello A, Danne T, De Block C, DeVries JH, Lind M, Mathieu C, Nørgaard K, Renard E, Wilmot EG.   +9 more
europepmc   +2 more sources

Insulin Pump Therapy: a Meta-Analysis [PDF]

Diabetes Care, 2003
To conduct a meta-analysis of the metabolic and psychosocial impact of continuous subcutaneous insulin infusion (CSII) therapy on adults, adolescents, and children.Studies were identified and data regarding study design, year of publication, sample size, patient's age, diabetes duration, and duration of CSII therapy were collected.
Jill, Weissberg-Benchell, Jeanne, Antisdel-Lomaglio, Roopa, Seshadri   +2 more
openaire   +3 more sources

Effectiveness of intravenous insulin pump therapy combined with levofloxacin in diabetic patients with lung infections: A retrospective observational study. [PDF]

Medicine (Baltimore)
Dou Y, Peng C, Zhou Y, Liu Y.
europepmc   +2 more sources

The impact of insulin pump therapy to oxidative stress in patients with diabetic nephropathy

European Journal of Medical Research, 2018
Background The oxidative stress resulting from increased production of ROS plays a crucial role in the development of diabetic complications. We aim to explore the relationships between oxidative stress, diabetic nephropathy (DN) and short-term insulin ...
Xing-Guang Zhang, Yan-Qi Zhang, Qian-Peng Cheng, Yi Cao, Jian-Min Sun, Xiao-Feng Lv   +5 more
doaj   +2 more sources

Patient experiences of continuous glucose monitoring and sensor-augmented insulin pump therapy for diabetes: A systematic review of qualitative studies. [PDF]

J Diabetes, 2023
Natale P, Chen S, Chow CK, Cheung NW, Martinez-Martin D, Caillaud C, Scholes-Robertson N, Kelly A, Craig JC, Strippoli G, Jaure A.   +10 more
europepmc   +3 more sources

Fully Closed-Loop Glucose Control Compared With Insulin Pump Therapy With Continuous Glucose Monitoring in Adults With Type 1 Diabetes and Suboptimal Glycemic Control: A Single-Center, Randomized, Crossover Study.

Diabetes Care, 2023
OBJECTIVE We evaluated the safety and efficacy of fully closed-loop with ultrarapid insulin lispro in adults with type 1 diabetes and suboptimal glycemic control compared with insulin pump therapy with continuous glucose monitoring (CGM).
C. Boughton, S. Hartnell, Rama Lakshman, Munachiso Nwokolo, M. Wilinska, J. Ware, Janet M. Allen, Mark L. Evans, R. Hovorka   +8 more
semanticscholar   +1 more source

Self‐Powered Syringe Pump for Insulin Pump Therapy Based on High‐Voltage Triboelectric Nanogenerator and Dielectric Elastomer Actuator

Advanced Functional Materials, 2023
Insulin pump therapy (IPT) is commonly utilized for treating type 1 diabetes. However, the insulin pump is generally rigid, and its prolonged use can cause discomfort to patients.
Yi Wei, Wenjie Wu, Yuhao Wang, Xiangyu Chen, Zhong‐Lin Wang, Dan Yang   +5 more
semanticscholar   +1 more source

The success of insulin pump therapy: importance of education of patients and health professionals. [PDF]

Front Clin Diabetes Healthc
Carić B, Marin S, Malinović-Pančić J, Malešević G, Mirnić D.   +4 more
europepmc   +3 more sources

Insulin Pump Therapy [PDF]

Diabetes Care, 2003
OBJECTIVE—To conduct a meta-analysis of the metabolic and psychosocial impact of continuous subcutaneous insulin infusion (CSII) therapy on adults, adolescents, and children. RESEARCH DESIGN AND METHODS—Studies were identified and data regarding study design, year of publication, sample size, patient’s age, diabetes duration, and ...
Jill Weissberg-Benchell, Jeanne Antisdel-Lomaglio, Roopa Seshadri   +2 more
openaire   +2 more sources

Long-term glycemic control and factors, associated with response to pump insulin therapy in children

Сахарный диабет, 2021
Background: In recent years, pump-based insulin therapy, also known as continuous subcutaneous insulin infusion (CSII), has become a common treatment for children with type 1 diabetes mellitus (T1DM). Despite the fact that, in general, children with type
D. N. Laptev, A. O. Emelyanov, E D Medvedeva, S. V. Pereverzeva, V. A. Peterkova   +4 more
doaj   +1 more source